Penumbra (PEN) Current Deferred Tax Assets (2014 - 2015)

Penumbra (PEN) reported Current Deferred Tax Assets of $7.3 million for Q3 2015, up 16.77% quarter-over-quarter from $6.3 million in Q4 2014.

Penumbra (PEN) Current Deferred Tax Assets (2014 - 2015) Analysis & Trends

Penumbra (PEN) has 2 years of Current Deferred Tax Assets data on file, last reported at $7.3 million in Q3 2015.

Current Deferred Tax Assets for Q3 2015 came in at $7.3 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2015 was $7.3 million (changed N/A YoY), and the FY2014 annual result was $6.3 million, changed N/A from the prior year.
Current Deferred Tax Assets advanced to $7.3 million in Q3 2015 per PEN's latest filing, from $6.3 million in the prior quarter.
Over five years, Current Deferred Tax Assets peaked at $7.3 million in Q3 2015 and troughed at $6.3 million in Q4 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn
10	Penumbra	12.51 Bn	11.90 Bn	253.41 Mn

Download Data